Feedback / Questions
pemvidutide (ALT-801) - Altimmune
https://www.globenewswire.com/news-release/2026/05/28/3303064/0/en/Pemvidutide-Demonstrates-Significant-Metabolic-Improvements-in-Patients-with-MASH-in-New-48-Week-IMPACT-Phase-2b-Data-Presented-at-EASL-2026.html
May 28, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next